Eric A. Rose M.D. is Director at ABIOMED INC (ABMD). They have made 14 open-market trades across 5 companies since 2006, most recently 2024-06-20.
CIK 0001139301
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $71K since 2008, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABMD | SELL | 2017-08-30 | 2017-09-01 | $145.17 | $285K | +5.5% | +12.8% | +29.4% |
| ABMD | SELL | 2017-08-24 | 2017-08-28 | $151.09 | $7.0M | +7.5% | +12.2% | +35.9% |
| ABMD | SELL | 2017-08-24 | 2017-08-28 | $150.67 | $1.8M | +7.5% | +12.2% | +35.9% |
| ABMD | SELL | 2016-11-30 | 2016-12-02 | $110.81 | $1.8M | +9.1% | +2.8% | +9.9% |
| SIGAQ | SELL | 2015-09-24 | 2015-09-24 | $1.21 | $24K | N/A | N/A | N/A |
| SIGAQ | SELL | 2015-09-01 | 2015-09-03 | $1.32 | $26K | N/A | N/A | N/A |
| SIGAQ | SELL | 2015-06-22 | 2015-06-24 | $1.43 | $36K | N/A | N/A | N/A |
| SIGAQ | SELL | 2015-06-02 | 2015-06-04 | $1.67 | $42K | N/A | N/A | N/A |
| ABMD | SELL | 2015-02-02 | 2015-02-04 | $51.44 | $772K | -3.4% | -4.0% | -4.0% |
| SIGA | SELL | 2011-05-19 | 2011-05-20 | $13.65 | $566K | +3.3% | +1.3% | +1.3% |
| SIGA | BUY | 2009-12-15 | 2009-12-15 | $6.00 | $43K | +3.3% | +1.3% | +1.3% |
| NEPH | SELL | 2009-06-10 | 2009-06-16 | $1.36 | $265K | +3.0% | -1.8% | -1.8% |
| SIGA | BUY | 2008-12-15 | 2008-12-17 | $3.06 | $28K | +3.3% | +1.3% | +1.3% |
| KERX | SELL | 2006-03-14 | 2006-03-16 | $18.11 | $91K | -32.6% | -1.8% | -1.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.